A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
NCT00288197 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 77
Last updated 2008-06-12
Summary
To evaluate the efficacy and safety of voriconazole in Chinese patients with proven or probable deep tissue fungal infections.
Conditions
- Invasive Fungal Infections
Interventions
- DRUG
-
voriconazole
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2007-06-30
- Completion
- 2007-06-30
Countries
- China
Study Locations
More Related Trials
-
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
NCT00059878 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001757 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Drug Monitoring of Voriconazole
NCT00890708 ·Status: COMPLETED ·Phase: NA
-
A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections
NCT00721578 ·Status: COMPLETED
-
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
NCT01416025 ·Status: COMPLETED ·Phase: PHASE4
-
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
NCT00238355 ·Status: TERMINATED ·Phase: PHASE2
-
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
NCT02180165 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
NCT00163111 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
NCT02100761 ·Status: UNKNOWN
-
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
NCT01782131 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)
NCT02387983 ·Status: COMPLETED ·Phase: PHASE1
-
Voriconazole for IPA in Chinese Patients With COPD
NCT02234739 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients
NCT01092832 ·Status: TERMINATED ·Phase: PHASE3
-
Voriconazole For Chronic Bronchopulmonary Aspergillosis
NCT00159822 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections
NCT06680544 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Voriconazole to Prevent Systemic Fungal Infections in Children
NCT00005912 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)
NCT03336502 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole
NCT01080651 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
NCT00940017 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
NCT01176058 ·Status: TERMINATED ·Phase: PHASE3
-
Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection
NCT01137292 ·Status: COMPLETED
-
Isavuconazole in Critically Ill Patients: Efficacy and Safety
NCT07080359 ·Status: NOT_YET_RECRUITING
-
Antifungal Use in Oncohematological Neutropenic Patients
NCT00386802 ·Status: COMPLETED ·Phase: PHASE4
-
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
NCT00531479 ·Status: COMPLETED ·Phase: PHASE3